Show simple item record

dc.contributor.authorde Andrés‑Nogales, Fernando
dc.contributor.authorCasado, Miguel Ángel
dc.contributor.authorTrillo, José Luis
dc.contributor.authorRuiz Moreno, José María
dc.contributor.authorMartínez Sesmero, José Manuel
dc.contributor.authorPeralta, Gemma
dc.contributor.authorPoveda, José Luis
dc.contributor.authorOrtiz, Pere
dc.contributor.authorIgnacio García, Emilio Francisco 
dc.contributor.authorZarranz Ventura, Javier
dc.contributor.authorUdaondo, Patricia
dc.contributor.authorMur, Carlos
dc.contributor.authorÁlvarez, Eloísa
dc.contributor.authorCervera, Enrique
dc.contributor.authorMartínez, Mercedes
dc.contributor.authorLlorente, Iñaki
dc.contributor.authorZulueta, Jacinto
dc.contributor.authorRodríguez Maqueda, Mariano
dc.contributor.authorGarcía Layana, Alfredo
dc.contributor.authorMartínez Olmos, José
dc.contributor.otherEnfermería y Fisioterapiaes_ES
dc.date.accessioned2020-03-13T10:26:02Z
dc.date.available2020-03-13T10:26:02Z
dc.date.issued2020-02
dc.identifier.issn2509-4262
dc.identifier.issn2509-4254
dc.identifier.urihttp://hdl.handle.net/10498/22606
dc.description.abstractBackground The clinical and economic management of retinal diseases has become more complex following the introduction of new intravitreal treatments. Multicriteria decision analysis (MCDA) offers the potential to overcome the challenges associated with traditional decision-making tools. Objectives A MCDA to determine the most relevant criteria to decision-making in the management of diabetic macular edema (DME) based on the perspectives of multiple stakeholders in Spain was developed. This MCDA was termed the MULTIDEX-EMD study. Methods Nineteen stakeholders (7 physicians, 4 pharmacists, 5 health authorities and health management experts, 1 psychologist, and 2 patient representatives) participated in this three-phase project. In phase A, an advisory board defined all of the criteria that could influence DME treatment decision-making. These criteria were then screened using a discrete choice experiment (DCE) (phase B). Next, a multinomial logit model was fitted by applying the backward elimination algorithm (relevant criteria: p value < 0.05). Finally, the results were discussed in a deliberative process (phase C). Results Thirty-one criteria were initially defined (phase A) and grouped into 5 categories: efficacy/effectiveness, safety, organizational and economic impact, patient-reported outcomes, and other therapeutic features. The DCE results (phase B) showed that 10 criteria were relevant to the decision-making process for a 50- to 65-year-old DME patient: mean change in best corrected visual acuity (p value < 0.001), percentage of patients with an improvement of >= 15 letters (p value < 0.001), effect duration per administration (p value = 0.008), retinal detachment (p value < 0.001), endophthalmitis (p value = 0.012), myocardial infarction (p value < 0.001), intravitreal hemorrhage (p value = 0.021), annual treatment cost per patient (p value = 0.001), health-related quality of life (HRQoL) (p value = 0.004), and disability level (p value = 0.021). Conclusions From a multi-stakeholder perspective, the selection of an appropriate treatment for DME patients should guarantee patient safety and maximize the visual acuity improvement and treatment effect duration. It should also contribute to system sustainability by being affordable, it should have a positive impact on HRQoL, and it should prevent disability.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherSPRINGER INTERNATIONAL PUBLISHING AGes_ES
dc.rightsAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.sourcePHARMACOECONOMICS-OPENes_ES
dc.titleA Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX‑EMD Studyes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1007/s41669-020-00201-2


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial 4.0 Internacional
This work is under a Creative Commons License Atribución-NoComercial 4.0 Internacional